135 related articles for article (PubMed ID: 21142090)
21. Development and characterization of mucoadhesive-thermoresponsive gels for the treatment of oral mucosa diseases.
Pagano C; Giovagnoli S; Perioli L; Tiralti MC; Ricci M
Eur J Pharm Sci; 2020 Jan; 142():105125. PubMed ID: 31682975
[TBL] [Abstract][Full Text] [Related]
22. Poloxamer 407 as a solubilising agent for tolfenamic acid and as a base for a gel formulation.
Cafaggi S; Russo E; Caviglioli G; Parodi B; Stefani R; Sillo G; Leardi R; Bignardi G
Eur J Pharm Sci; 2008 Sep; 35(1-2):19-29. PubMed ID: 18598763
[TBL] [Abstract][Full Text] [Related]
23. Rheological characterization and in vivo evaluation of thermosensitive poloxamer-based hydrogel for intramuscular injection of piroxicam.
Xuan JJ; Balakrishnan P; Oh DH; Yeo WH; Park SM; Yong CS; Choi HG
Int J Pharm; 2010 Aug; 395(1-2):317-23. PubMed ID: 20573569
[TBL] [Abstract][Full Text] [Related]
24. Injectable and sustained delivery of human growth hormone using chemically modified Pluronic copolymer hydrogels.
Park SY; Chung HJ; Lee Y; Park TG
Biotechnol J; 2008 May; 3(5):669-75. PubMed ID: 18246570
[TBL] [Abstract][Full Text] [Related]
25. Release of ciprofloxacin from poloxamer-graft-hyaluronic acid hydrogels in vitro.
Cho KY; Chung TW; Kim BC; Kim MK; Lee JH; Wee WR; Cho CS
Int J Pharm; 2003 Jul; 260(1):83-91. PubMed ID: 12818813
[TBL] [Abstract][Full Text] [Related]
26. Controlled release ibuprofen-poloxamer gel for epidural use - A pharmacokinetic study using microdialysis in pigs.
Paavola A; Bernards CM; Rosenberg PH
Eur J Pharm Biopharm; 2016 Nov; 108():180-186. PubMed ID: 27615997
[TBL] [Abstract][Full Text] [Related]
27. Poloxamer 407 microspheres for orotransmucosal drug delivery. Part I: formulation, manufacturing and characterization.
Albertini B; Passerini N; Di Sabatino M; Monti D; Burgalassi S; Chetoni P; Rodriguez L
Int J Pharm; 2010 Oct; 399(1-2):71-9. PubMed ID: 20696227
[TBL] [Abstract][Full Text] [Related]
28. A novel injectable in situ forming gel based on carboxymethyl hexanoyl chitosan/hyaluronic acid polymer blending for sustained release of berberine.
Lu KY; Lin YC; Lu HT; Ho YC; Weng SC; Tsai ML; Mi FL
Carbohydr Polym; 2019 Feb; 206():664-673. PubMed ID: 30553371
[TBL] [Abstract][Full Text] [Related]
29. Mucoadhesive and penetration enhancement properties of three grades of hyaluronic acid using porcine buccal and vaginal tissue, Caco-2 cell lines, and rat jejunum.
Sandri G; Rossi S; Ferrari F; Bonferoni MC; Zerrouk N; Caramella C
J Pharm Pharmacol; 2004 Sep; 56(9):1083-90. PubMed ID: 15324476
[TBL] [Abstract][Full Text] [Related]
30. Novel mucoadhesive nasal inserts based on chitosan/hyaluronate polyelectrolyte complexes for peptide and protein delivery.
Luppi B; Bigucci F; Mercolini L; Musenga A; Sorrenti M; Catenacci L; Zecchi V
J Pharm Pharmacol; 2009 Feb; 61(2):151-7. PubMed ID: 19178761
[TBL] [Abstract][Full Text] [Related]
31. Effect of DMSO on micellization, gelation and drug release profile of Poloxamer 407.
Ur-Rehman T; Tavelin S; Gröbner G
Int J Pharm; 2010 Jul; 394(1-2):92-8. PubMed ID: 20472044
[TBL] [Abstract][Full Text] [Related]
32. In vitro and in vivo release of albumin using a biodegradable MPEG-PCL diblock copolymer as an in situ gel-forming carrier.
Hyun H; Kim YH; Song IB; Lee JW; Kim MS; Khang G; Park K; Lee HB
Biomacromolecules; 2007 Apr; 8(4):1093-100. PubMed ID: 17326678
[TBL] [Abstract][Full Text] [Related]
33. Development of dorzolamide hydrochloride in situ gel nanoemulsion for ocular delivery.
Ammar HO; Salama HA; Ghorab M; Mahmoud AA
Drug Dev Ind Pharm; 2010 Nov; 36(11):1330-9. PubMed ID: 20545523
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and characterization of thermally responsive Pluronic F127-chitosan nanocapsules for controlled release and intracellular delivery of small molecules.
Zhang W; Gilstrap K; Wu L; K C RB; Moss MA; Wang Q; Lu X; He X
ACS Nano; 2010 Nov; 4(11):6747-59. PubMed ID: 21038924
[TBL] [Abstract][Full Text] [Related]
35. Encapsulation of the growth factor neurotrophin-3 in heparinised poloxamer hydrogel stabilises bioactivity and provides sustained release.
Meissner S; Rees S; Nguyen L; Connor B; Barker D; Harland B; Raos B; Svirskis D
Biomater Adv; 2024 May; 159():213837. PubMed ID: 38522310
[TBL] [Abstract][Full Text] [Related]
36. Comparative study of nanosized cross-linked sodium-, linear sodium- and zinc-hyaluronate as potential ocular mucoadhesive drug delivery systems.
Horvát G; Budai-Szűcs M; Berkó S; Szabó-Révész P; Soós J; Facskó A; Maroda M; Mori M; Sandri G; Bonferoni MC; Caramella C; Csányi E
Int J Pharm; 2015 Oct; 494(1):321-8. PubMed ID: 26319587
[TBL] [Abstract][Full Text] [Related]
37. Poloxamer-based in situ gelling thermoresponsive systems for ocular drug delivery applications.
Soliman KA; Ullah K; Shah A; Jones DS; Singh TRR
Drug Discov Today; 2019 Aug; 24(8):1575-1586. PubMed ID: 31175956
[TBL] [Abstract][Full Text] [Related]
38. Sustained-release of urease from a poloxamer gel matrix.
Fults KA; Johnston TP
J Parenter Sci Technol; 1990; 44(2):58-65. PubMed ID: 2338605
[TBL] [Abstract][Full Text] [Related]
39. Mucoadhesive and physicochemical characterization of Carbopol-Poloxamer gels containing triamcinolone acetonide.
Shin SC; Kim JY; Oh IJ
Drug Dev Ind Pharm; 2000 Mar; 26(3):307-12. PubMed ID: 10738647
[TBL] [Abstract][Full Text] [Related]
40. Accelerated release of a sparingly soluble drug from an injectable hyaluronan-methylcellulose hydrogel.
Wang Y; Lapitsky Y; Kang CE; Shoichet MS
J Control Release; 2009 Dec; 140(3):218-23. PubMed ID: 19470396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
